Anti-tumor effects of oxytetracycline, propafenone and dipyrone
Patent Information
- Authority / Receiving Office
- CN ยท China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ้ต้่พ
- Publication Date
- 2014-01-29
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to the new functions of the anti-tumor effect of the three drugs. Specifically, the present invention relates to three non-clinical antitumor drugs, which are found to have antitumor effects, mainly to significantly inhibit the proliferation of lung cancer A549 cells or cervical cancer Hela cells. Background technique
[0002] Clinical trials are the last step in the development of new drugs, and they cost huge sums of money. The new use of old drugs, especially the discovery of new uses of "old drugs" that have been used in long-term clinical practice, is of great significance, and its value is by no means lower than that of discovering a new drug. At present, there is almost no drug that can completely cure cancer patients such as lung cancer or cervical cancer. Therefore, it is very important to find an effective, specific, and less toxic and side effect new anti-tumor drug.
[0003] Many new uses of old drugs are dis...